Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 63.92B | 64.17B | 63.17B | 62.48B | 61.40B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 63.92B | 64.17B | 63.17B | 62.48B | 61.40B |
| Cost of Revenue | 14.66B | 14.70B | 14.79B | 15.13B | 15.44B |
| Gross Profit | 49.27B | 49.47B | 48.39B | 47.35B | 45.96B |
| SG&A Expenses | 10.19B | 10.10B | 10.05B | 9.85B | 9.84B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.98B | 40.75B | 45.75B | 43.33B | 43.39B |
| Operating Income | 22.94B | 23.42B | 17.43B | 19.15B | 18.01B |
| Income Before Tax | 20.17B | 19.94B | 13.72B | 15.25B | 3.91B |
| Income Tax Expenses | 2.72B | 2.80B | 1.56B | 1.50B | 1.59B |
| Earnings from Continuing Operations | 17.45K | 17.13K | 12.16K | 13.75K | 2.32K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -17.00M | -16.00M | -15.00M | -16.00M | -13.00M |
| Net Income | 17.43B | 17.12B | 12.15B | 13.74B | 2.31B |
| EBIT | 22.94B | 23.42B | 17.43B | 19.15B | 18.01B |
| EBITDA | 27.33B | 27.67B | 21.46B | 23.01B | 21.69B |
| EPS Basic | 6.89 | 6.75 | 4.79 | 5.42 | 0.91 |
| Normalized Basic EPS | 5.48 | 5.57 | 4.09 | 4.45 | 4.21 |
| EPS Diluted | 6.87 | 6.73 | 4.77 | 5.39 | 0.89 |
| Normalized Diluted EPS | 5.46 | 5.56 | 4.08 | 4.43 | 4.19 |
| Average Basic Shares Outstanding | 10.13B | 10.14B | 10.13B | 10.14B | 10.14B |
| Average Diluted Shares Outstanding | 10.15B | 10.17B | 10.16B | 10.17B | 10.16B |
| Dividend Per Share | 3.12 | 3.08 | 3.04 | 3.00 | 2.96 |
| Payout Ratio | 45.54% | 45.80% | 63.72% | 55.64% | 327.06% |